We are live on
!
Find out more
AC
Argentiere Capital Portfolio holdings
AUM
$15.4M
1-Year Est. Return
8.82%
This Fund
S&P 500
This Quarter
Est. Return
-0.52%
1 Year Est. Return
-8.82%
3 Year Est. Return
+1.98%
5 Year Est. Return
+9.17%
10 Year Est. Return
–
AUM
$162M
AUM Growth
-$97.3M
(-37%)
Cap. Flow
-$64.8M
Cap. Flow
% of AUM
-39.91%
Top 10 Holdings %
Top 10 Hldgs %
82.19%
Holding
49
New
8
Increased
4
Reduced
9
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aon
AON
|
+$3.04M |
| 2 |
Bunge Global
BG
|
+$2.38M |
| 3 |
Eli Lilly
LLY
|
+$1.12M |
| 4 |
SHPG
Shire pic
SHPG
|
+$445K |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$435K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$24.6M |
| 2 |
United Therapeutics
UTHR
|
+$13.6M |
| 3 |
NXP Semiconductors
NXPI
|
+$12.7M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$8.16M |
| 5 |
United States Oil Fund
USO
|
+$7.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.19% |
| 2 | Materials | 19.43% |
| 3 | Communication Services | 19.31% |
| 4 | Financials | 13.93% |
| 5 | Healthcare | 9.8% |
Similar funds
TCM
HCA
DPA
MP
MMPI
AF
KAM
BA
Argentiere Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Argentiere Capital held 49 positions worth $162M, down 37% from $260M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Argentiere Capital withdrew a net $64.8M in Q4 2017, closing 18 positions and reducing 9 holdings. Its most notable exit was United Therapeutics, an estimated $13.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Materials and Communication Services.
Against the trend, Argentiere Capital opened a new position in Aon worth $2.86M.
- Argentiere Capital's largest Q4 2017 buy was Aon: 21,346 shares worth $2.86M.
- Argentiere Capital added most to Shire pic in Q4 2017, an estimated $445K increase.
- Argentiere Capital's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $24.6M.
- Argentiere Capital fully exited United Therapeutics in Q4 2017, selling an estimated $13.6M.
- Argentiere Capital's ten largest holdings make up 82% of its $162M portfolio in Q4 2017.
- Argentiere Capital opened 8 new positions and closed 18 in Q4 2017.
- Argentiere Capital's portfolio value fell 37% quarter-over-quarter to $162M.
Based on Argentiere Capital's 13F filing for Q4 2017, filed 14 Feb 2018.